Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48.

Article  CAS  PubMed  Google Scholar 

O’Reilly EA, Gubbins L, Sharma S, Tully R, Guang MH, Weiner-Gorzel K, et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 2015;3:257–75.

Article  PubMed  PubMed Central  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403.

Article  PubMed  Google Scholar 

Yan X, Xie Y, Yang F, Hua Y, Zeng T, Sun C, et al. Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. J Exp Clin Cancer Res. 2021;40:142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehraj U, Dar AH, Wani NA, Mir MA. Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemother Pharmacol. 2021;87:147–58.

Article  PubMed  Google Scholar 

Allison E, Edirimanne S, Matthews J, Fuller SJ. Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis. Oncol Ther. 2023;11:27–48.

Article  PubMed  Google Scholar 

Li H, Yang P, Wang J, Zhang J, Ma Q, Jiang Y, et al. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol. 2022;15:2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han D, Wang L, Long L, Su P, Luo D, Zhang H, et al. The E3 Ligase TRIM4 facilitates SET ubiquitin-mediated degradation to enhance ER-alpha action in breast cancer. Adv Sci. 2022;9:e2201701.

Article  Google Scholar 

Liu Z, Hou P, Fang J, Zhu J, Zha J, Liu R, et al. Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan. Oncogene. 2023;42:3221–35.

Article  PubMed  Google Scholar 

Zhao SJ, Kong FQ, Jie J, Li Q, Liu H, Xu AD, et al. Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K/AKT/GSK3beta/beta-catenin pathway. Theranostics. 2020;10:17–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han D, Wang L, Jiang S, Yang Q. The ubiquitin-proteasome system in breast cancer. Trends Mol Med. 2023;29:599–621.

Article  CAS  PubMed  Google Scholar 

Zhang H, Chen Z, Miranda RN, Medeiros LJ, McCarty N. TG2 and NF-kappaB signaling coordinates the survival of mantle cell lymphoma cells via IL6-mediated autophagy. Cancer Res. 2016;76:6410–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim S, Williams DW, Lee C, Kim T, Arai A, Shi S, et al. IL-36 induces bisphosphonate-related osteonecrosis of the jaw-like lesions in mice by inhibiting TGF-beta-mediated collagen expression. J Bone Miner Res. 2017;32:309–18.

Article  PubMed  Google Scholar 

Wu Q, Siddharth S, Sharma D. Triple negative breast cancer: a mountain yet to be scaled despite the triumphs. Cancers. 2021;13:3697.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meredith AM, Dass CR. Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J Pharm Pharmacol. 2016;68:729–41.

Article  CAS  PubMed  Google Scholar 

Pabalan N, Tharabenjasin P, Phababpha S, Jarjanazi H. Association of COL5A1 gene polymorphisms and risk of tendon-ligament injuries among Caucasians: a meta-analysis. Sports Med Open. 2018;4:46.

Article  PubMed  PubMed Central  Google Scholar 

Tsai HF, Chang YC, Li CH, Chan MH, Chen CL, Tsai WC, et al. Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling. Cell Death Discov. 2021;7:313.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, et al. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Theranostics. 2021;11:1473–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu YH, Huang YF, Chang TH, Chen CC, Wu PY, Huang SC, et al. COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta3 through the NF-kappaB/IGFBP2 axis in ovarian cancer cells. Oncogene. 2021;40:4503–19.

Article  CAS  PubMed  Google Scholar 

Yang M, Lu Z, Yu B, Zhao J, Li L, Zhu K, et al. COL5A1 promotes the progression of gastric cancer by acting as a ceRNA of miR-137-3p to upregulate FSTL1 expression. Cancers. 2022;14:3244.

Article  PubMed  PubMed Central  Google Scholar 

Feng G, Ma HM, Huang HB, Li YW, Zhang P, Huang JJ, et al. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res. 2019;11:1263–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu H, Hu X, Feng S, Jian Z, Xu X, Gu L, et al. The hypoxia-related gene COL5A1 is a prognostic and immunological biomarker for multiple human tumors. Oxid Med Cell Longev. 2022;2022:6419695.

PubMed  PubMed Central  Google Scholar 

Zhang J, Zhang J, Wang F, Xu X, Li X, Guan W, et al. Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer. J Cell Physiol. 2021;236:6907–19.

Article  CAS  PubMed  Google Scholar 

Nissen NI, Karsdal M, Willumsen N. Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology. J Exp Clin Cancer Res. 2019;38:115.

Article  PubMed  PubMed Central  Google Scholar 

Soltani A, Torki S, Ghahfarokhi MS, Jami MS, Ghatrehsamani M. Targeting the phosphoinositide 3-kinase/AKT pathways by small molecules and natural compounds as a therapeutic approach for breast cancer cells. Mol Biol Rep. 2019;46:4809–16.

Article  CAS  PubMed  Google Scholar 

Wu DM, Zhang T, Liu YB, Deng SH, Han R, Liu T, et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling. Cell Death Dis. 2019;10:349.

Article  PubMed  PubMed Central  Google Scholar 

Rahmani F, Ziaeemehr A, Shahidsales S, Gharib M, Khazaei M, Ferns GA, et al. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma. J Cell Physiol. 2020;235:4146–52.

Article  CAS  PubMed  Google Scholar 

Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, et al. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11:797.

Article  PubMed  PubMed Central  Google Scholar 

Shen L, Yang M, Lin Q, Zhang Z, Zhu B, Miao C. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Oncol Rep. 2016;36:877–85.

Article  CAS  PubMed  Google Scholar 

Muszynska A, Wolczynski S, Palka J. The mechanism for anthracycline-induced inhibition of collagen biosynthesis. Eur J Pharmacol. 2001;411:17–25.

Article  CAS  PubMed  Google Scholar 

Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010;70:5728–39.

Article  CAS  PubMed  Google Scholar 

De Logu F, Ugolini F, Iannone LF, Simi S, Maio V, de Giorgi V, et al. Spatial proximity and relative distribution of tumor-infiltrating lymphocytes and macrophages predict survival in melanoma. Lab Investig. 2023;103:100259.

Article  PubMed  Google Scholar 

Wang X, Wang J, Zhao J, Wang H, Chen J, Wu J. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment. Theranostics. 2022;12:963–75.

Article  PubMed  PubMed Central  Google Scholar 

Jiang Y, Qu X, Zhang M, Zhang L, Yang T, Ma M, et al. Identification of a six-gene prognostic signature for bladder cancer associated macrophage. Front Immunol. 2022;13:930352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu CS, Shiau AL, Su BH, Hsu TS, Wang CT, Su YC, et al. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. J Hematol Oncol. 2020;13:62.

Article  CAS  PubMed  PubMed Central